Thermo Fisher Scientific Inc

TMO · Healthcare

$600.50

Κεφαλαιοποίηση: 222.03B USDΜερισματική απόδοση: +0.30%
AdvanceΕίναι καλή στιγμή να αγοράσεις Thermo Fisher Scientific Inc; Ρώτα το Copenvest AIΠάρε μια Advance AI άποψη για timing, ρίσκο και τι κάνουν οι παρακολουθούμενοι επενδυτές.Ρώτα το Copenvest AI

Φόρτωση γραφήματος…

Νέα

Τελευταίοι τίτλοι για αυτή τη μετοχή

GlobeNewswire Inc.4 Σεπ 2026, 9:48 π.μ.

Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays with 68% Market Share

The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with 34% market share, while Asia Pacific is the fastest-growing region at 15.5% CAGR. Consumables dominate with 68% market share, and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, and laboratory automation.

Zacks Investment Research1 Σεπ 2026, 6:29 μ.μ.

TMO Stock Could Gain Following the Launch of EMPAD G2 Detector

Thermo Fisher Scientific unveiled the EMPAD G2 detector, enabling faster 4D STEM materials analysis at 10,000 frames per second with atomic-scale characterization. The detector integrates with Velox software for simplified analysis. The global 4D STEM market is projected to grow from $68 million in 2024 to $110 million by 2031 at a 6.6% CAGR, supporting TMO's growth prospects in analytical instruments.

GlobeNewswire Inc.31 Αυγ 2026, 9:04 π.μ.

Lateral Flow Assay Market Size, Industry Dynamics, Opportunity Analysis and Forecast 2026-2035

The global lateral flow assay market is projected to grow from USD 10.84 billion in 2025 to USD 17.66 billion by 2035, with a 5.0% CAGR. Growth is driven by increased adoption of point-of-care testing, technological innovations including CRISPR-based assays, and the shift toward decentralized diagnostic models. Major players include Abbott, Roche, Siemens Healthineers, and Thermo Fisher Scientific, with infectious disease testing accounting for 72.2% of market share.

GlobeNewswire Inc.27 Αυγ 2026, 5:00 μ.μ.

Global Blood-Based Biomarkers Market to Witness Upsurge in Growth at a CAGR of ~9% by 2034 | DelveInsight

The global blood-based biomarkers market is projected to grow from USD 8.5 billion in 2025 to USD 18.5 billion by 2034, driven by increasing demand for non-invasive diagnostics, rising chronic disease prevalence, and advances in genomics and liquid biopsy technologies. North America leads with 44% market share, while Asia-Pacific shows fastest growth. Key players include Roche, Abbott, Siemens Healthineers, and Thermo Fisher Scientific.

GlobeNewswire Inc.27 Αυγ 2026, 3:00 μ.μ.

Laboratory Informatics Market to Grow from USD 4.08 Billion in 2025 to USD 6.69 Billion by 2035, at a CAGR of 5.06% - SNS Insider

The global laboratory informatics market is projected to grow at a CAGR of 5.06% from 2025 to 2035, driven by increased data processing demands, regulatory compliance requirements, and adoption of cloud-native solutions and AI-driven analytics. North America leads with 42.55% market share, while Asia-Pacific is the fastest-growing region. Services and LIMS products dominate, with cloud delivery and electronic lab notebooks showing the strongest growth rates.